Differentiation of Classical Swine Fever Virus Infection from CP7_E2alf Marker Vaccination by a Multiplex Microsphere Immunoassay
Open Access
- 5 November 2014
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 22 (1) , 65-71
Abstract
Classical swine fever (CSF) is a highly contagious viral disease of pigs that has a tremendous socioeconomic impact. Vaccines are available for disease control. However, most industrialized countries are implementing stamping-out strategies to eliminate the disease and avoid trade restrictions. These restrictions can be avoided through the use of marker vaccines such as CP7_E2alf. Marker vaccines have to be accompanied by reliable and robust discriminatory assays. In this context, a multiplex microsphere immunoassay for serological differentiation of infected from vaccinated animals (DIVA) was developed to distinguish CSF virus (CSFV)-infected animals from CP7_E2alf-vaccinated animals. To this end, three viral proteins, namely, CSFV E2, CSFV Erns, and bovine viral diarrhea virus (BVDV) E2, were produced in insect cells using a baculovirus expression system; they were used as antigens in a microsphere immunoassay, which was further evaluated by testing a large panel of pig sera and compared to a well-characterized commercial CSFV E2 antibody enzyme-linked immunosorbent assays (ELISAs) and a test version of an improved CSFV Ernsantibody ELISA. Under a cutoff median fluorescence intensity value of 5,522, the multiplex microsphere immunoassay had a sensitivity of 98.5% and a specificity of 98.9% for the detection of antibodies against CSFV E2. The microsphere immunoassay and the CSFV ErnsELISA gave the same results for 155 out of 187 samples (82.8%) for the presence of CSFV Ernsantibodies. This novel multiplex immunoassay is a valuable tool for measuring and differentiating immune responses to vaccination and/or infection in animals.Keywords
This publication has 23 references indexed in Scilit:
- Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: Protection and DIVA characteristicsVeterinary Microbiology, 2013
- Two newly developed Erns-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodiesVeterinary Microbiology, 2013
- Comparative evaluation of live marker vaccine candidates “CP7_E2alf” and “flc11” along with C-strain “Riems” after oral vaccinationVeterinary Microbiology, 2012
- Towards licensing of CP7_E2alf as marker vaccine against classical swine fever—Duration of immunityVaccine, 2012
- Innocuousness and safety of classical swine fever marker vaccine candidate CP7_E2alf in non-target and target speciesVaccine, 2011
- Classical swine fever: Comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigsVeterinary Microbiology, 2010
- Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunizationVaccine, 2009
- Novel marker vaccines against classical swine feverVaccine, 2007
- CP7_E2alf: A safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV)Vaccine, 2007
- Detection of antibodies against classical swine fever virus in swine sera by indirect ELISA using recombinant envelope glycoprotein E2Veterinary Microbiology, 1996